Showing results (51-60 of 639) with videos related to
Sort By:
Pageof 64
Agents and Actions|August 1, 1990
Protective effect of rimexolone on cartilage damage in arthritic mice: a comparative study with triamcinolone hexacetonideL A Joosten, M M Helsen, W B van den BergDrug Metabolism and Drug Interactions|January 1, 1989
The polymorphonuclear leukocyte: its pharmacological transport and target properties: an overviewM Raghoebar, W B Van den Berg, C A Van GinnekenClinical and Experimental Immunology|August 1, 1994
Accelerated onset of collagen-induced arthritis by remote inflammationL A Joosten, M M Helsen, W B van den BergArthritis Research & Therapy|March 26, 2013
Mesenchymal stem cell therapy in osteoarthritis: advanced tissue repair or intervention with smouldering synovial activation?Peter L E M van Lent, Wim B van den BergInternational Journal of Tissue Reactions|January 1, 1987
Alteration of chloroquine accumulation in human polymorphonuclear leucocytes under inflammatory conditionsM Raghoebar, W B van den Berg, C A van GinnekenClinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|August 1, 1987
A simple and accurate automated system for continuous long-term metabolic studies during artificial ventilationH Stam, B van den Berg, J M Bogaard, et al.Biochemical Pharmacology|April 1, 1988
Mechanisms of cell association of some non-steroidal anti-inflammatory drugs with isolated leucocytesM Raghoebar, W B Van den Berg, C A Van GinnekenBiochimica Et Biophysica Acta|October 26, 1984
A re-evaluation of conditions required for an accurate estimation of the extramitochondrial ATP/ADP ratio in isolated rat-liver mitochondriaR J Wanders, G B Van den Berg, J M TagerThe Journal of Rheumatology|April 1, 1991
Transient chondrocyte nonresponsiveness to insulin-like growth factor-1 upon H2O2 exposure is not related to IGF receptor damageL A Joosten, M M Helsen, W B van den BergRheumatic Diseases Clinics of North America|February 14, 2002
Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulatorsFons A J van de Loo, Wim B van den BergPageof 64